⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Efficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Efficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04)

Official Title: A PHASE III STUDY OF VELCADE (BORTEZOMIB) THALIDOMIDE DEXAMETHASONE (VTD) VERSUS VELCADE (BORTEZOMIB) CYCLOPHOSPHAMIDE DEXAMETHASONE (VCD) AS AN INDUCTION TREATMENT PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA."

Study ID: NCT01971658

Study Description

Brief Summary: This is a phase III, multicenter, prospective with a clinical benefit, open-label and randomized study to compare two different treatments : Velcade (Bortezomib) Thalidomide Dexamethasone (VTD) versus Velcade (Bortezomib) Cyclophosphamide Dexamethasone (VCD) as an Induction Treatment prior to Autologous Stem Cell Transplantation in patients with Newly Diagnosed Multiple Myeloma. Eligible patients will be randomized into 2 treatment arms. Each patient will receive 4 consecutive 21 day cycles of an induction treatment with either VTD or VCD.

Detailed Description: The patient population will consist of adult men and women who have a confirmed diagnosis of Multiple Myeloma and who meet eligibility criteria. They will be recruited from among the patients consulting in an investigating centre's haematology service for newly diagnosed, symptomatic, untreated multiple myeloma. in each treatment arm there will be : 1. Induction therapy : 4 cycles of VTD (21 days)or VCD 2. Systematic stem cell harvest after cycle 3

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Centre Hospitalier de la région d'Annecy, Annecy, Pringy, France

CHRU Hôpital Sud, Amiens, , France

CHU Angers, Angers, , France

Centre Hospitalier Argenteuil, Argenteuil, , France

Centre Hospitalier H.Duffaut, Avignon, , France

Centre Hospitalier de la Côte Basque, Bayonne, , France

CHRU de Besançon, Besançon, , France

Hôpital Avicenne, Bobigny, , France

Polyclinique Bordeaux Nord Aquitaine, Bordeaux, , France

Centre hospitalier Pierre Oudot, Bourgoin Jallieu, , France

Hôpital A.Morvan, Brest, , France

CHU Caen Côte de Nacre, Caen, , France

CH René Dubos, Cergy-pontoise, , France

Centre Hospitalier William Morey, Chalon/saone, , France

Hôpital d'instruction des armées Percy, Clamart, , France

CHU d'Estaing, Clermont-ferrand, , France

Hôpitaux civils de Colmar, Colmar, , France

Centre Hospitalier Sud Francilien, Corbeil-essonnes, , France

CHU Henri Mondor, Creteil, , France

CHRU Dijon, Dijon, , France

Centre Hospitalier Général, Dunkerque, , France

CHRU - Hôpital A.Michallon, Grenoble, , France

Centre hospitalier départemental Vendée, La Roche Sur Yon, , France

Hôpital Louis Pasteur, Le Coudray, , France

Centre Jean Bernard, Le Mans, , France

CH Le Mans, Le Mans, , France

Hopital Saint Vincent de Paul, Lille, , France

CHRU - Hôpital Claude Huriez, Lille, , France

CHU de Limoges, Limoges, , France

Hôpital Du Scorff, Lorient, , France

Centre Léon Bérard, Lyon, , France

Institut Paoli Calmettes, Marseille, , France

Centre Hospitalier de Meaux, Meaux, , France

CHR Metz Thionville, Metz, , France

Centre Hospitalier intercommunale Meulan les mureaux, Meulan, , France

Hopital E Muller, Mulhouse, , France

Nantes University Hospital, Nantes, , France

Hôpital de l'Archet 1, Nice, , France

Groupe Hospitalo-Universitaire Carémeau, Nimes, , France

CHU - Hôpital St-Antoine, PARIS cedex 12, , France

Institut CURIE, Paris, , France

Hôpital Cochin, Paris, , France

CHU - Hôpital St-Antoine, Paris, , France

Hôpital Pitié-Salpétrière, Paris, , France

AP-HP Hôpital Necker, Paris, , France

Centre Hospitalier de PERIGUEUX, Perigueux, , France

CH Saint Jean, Perpignan, , France

CHRU - Hôpital du Haut Lévêque, Pessac, , France

Centre Hospitalier Lyon sud, Pierre Benite, , France

CHRU - Hôpital Jean Bernard, Poitiers, , France

Hôpital R.Debré, Reims, , France

CHRU - Hôpital de Pontchaillou, Rennes, , France

Centre Henri Becquerel, Rouen, , France

Centre Hospitalier, Saint Quentin, , France

Centre Hospitalier Yves le Foll, St Brieuc, , France

Centre René Huguenin, St Cloud, , France

Centre hospitalier, ST Malo, , France

Institut de Cancérologie de la Loire, St Priest-en-jarez, , France

Hôpitaux Universitaires de Strasbourg, Strasbourg, , France

CHRU - Hôpital Purpan, Toulouse, , France

CHRU - Hôpital Bretonneau, Tours, , France

CHRU - Hôpitaux de Brabois, Vandoeuvre Les Nancy, , France

CH Bretagne Atlantique Vannes et Auray, Vannes, , France

Contact Details

Name: Philippe MOREAU

Affiliation: Nantes University Hospital

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: